Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis

Joosten, LPT; van Maanen, R; van den Dries, CJ; Rutten, FH; Hoes, AW; Granger, CB; Hemels, MEW; Geersing, GJ; van Doorn, S

van Doorn, S (通讯作者),Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Dept Gen Practice, Utrecht, Netherlands.

OPEN HEART, 2023; 10 (1):

Abstract

ObjectivePostmarketing observational studies report that a substantial percentage of patients with atrial fibrillation (AF) receive a reduced non-vita......

Full Text Link